Supply Chain Traceability for Pharmaceutical Companies
42% of pharma supply chain breaches go undetected for over 90 days. Your distributor network spans dozens of tiers. Without traceability at every handoff, you are flying blind.
Your Supply Chain Is Leaking. The Data Confirms It.
Most QA heads find out about a traceability gap when a regulator calls or a recall goes wrong. The warning signs were in the data all along. Your team just did not have a system to see them.
Six Points in Your Supply Chain Where You Are Currently Flying Blind
Your direct distributor confirmed delivery. But where did it go after that? Without scan events at sub-distributors and last-mile agents, three tiers of your network are invisible to you.
A temperature-sensitive product arrived at the pharmacy. The patient says it did not work. You have no timestamped temperature log from transit. Now your team is managing a claim with no data to defend or disprove it.
Repackagers strip original cartons and repack in smaller quantities. Batch numbers get mixed across packs. When a quality issue emerges, tracing it back to the source batch takes weeks because the chain broke at the repackaging step.
A regulator issues a recall notice. Your team starts calling distributors manually. Three days later you still do not know which pharmacies received the affected batch. Traceability turns a three-day scramble into a two-hour pull.
An inspector asks for the complete chain of custody for a specific batch from manufacturing date to dispense. You pull from five different spreadsheets across three teams. The audit takes twice as long as it should.
Product destined for India gets diverted to a market where your price is higher. Your authorised channel in the destination market complains. You have no GPS scan data to prove where it went.
Four Traceability Mandates Your Team Is Already Tracking
Each of these regulations requires a documented chain of custody. If you sell into the US, EU, or India, at least two of them apply to you today. Acviss maps to each so you are not running separate systems for separate markets.
DSCSA requires every trading partner to exchange Transaction Information, Transaction History, and Transaction Statements at each sale. From November 2023, full system interoperability is mandatory. Every handoff from manufacturer to wholesaler to dispenser must be captured and available for FDA audit on demand.
The Falsified Medicines Directive requires a continuous verification chain from the moment a pack is serialised at the manufacturer to the point it is decommissioned at dispense. Each scan at a wholesaler, hospital, or pharmacy is a record in that chain. Breaks in the chain are reportable events.
Revised Schedule M requires batch-level traceability from raw material receipt through manufacturing, QC release, and distribution. CDSCO inspectors expect a full audit trail for each batch on Form 41. If you export, CDSCO serialisation requirements for drug exports are already phasing in.
WHO-GMP requires documented traceability of every batch from starting materials to final product release and distribution. PIC/S guidelines, adopted by 53 countries, extend this to supply chain documentation post-release. If your product is exported to any PIC/S member country, full traceability documentation is expected.
Track. Verify. Protect Your Channels.
Three products built to work together. Start with the layer that solves your most pressing problem right now and add the others when you are ready.
Blockchain chain of custody from your plant to the pharmacy shelf. When a regulator calls, your team pulls the full trace in seconds. When product goes off-course, Origin flags it before the patient receives it.
- Blockchain chain of custody from plant to shelf
- GPS-tagged scan at every supply chain node
- Cold chain temperature logging with timestamps
- Automatic diversion alert for unexpected geography
- Full batch recall execution in hours not days
- CDSCO Form 41 and WHO-GMP audit trail export
Pack-level scan events feed directly into the Origin traceability chain. Every tamper-evident label is a data point in your custody record. Your QA team sees every handoff from a single dashboard.
- Unique pack ID generation at line speed
- Tamper-evident label triggers scan event at each handoff
- Consumer scan confirms last-mile delivery
- Batch dashboard for QA review and sign-off
- EMVS-compatible for EU market requirements
- DSCSA data elements out of the box
Online channel monitoring catches diverted product appearing on wrong-market platforms before it scales. When serial number anomalies flag a diversion event, your legal team already has the evidence package ready.
- Detects your product listed in markets you do not authorise
- Flags serial number anomalies from diverted stock
- Platform takedown evidence packaging
- Grey market monitoring by geography
- Brand impersonation alerts
- Weekly intelligence report for your legal team
See How Acviss Supports Pharma Track And Trace
Get a tailored track and trace plan for your Pharma products and channels.
- ✅ Risk Audit: We map your Pharma product, channel, and customer journey.
- ✅ Live Demo: See Acviss track and trace workflows on your use case.
- ✅ Tailored Rollout: Get a practical deployment plan for your products and existing systems.
Trusted by Leading Brands
Protect Products.Build Trust.
What Pharma Teams Ask Before They Start
You Cannot Manage What You Cannot See.
80+ brands across 11+ countries use Acviss to track their products from plant to patient. Book a call and we will show you what your supply chain actually looks like right now.
